Your browser is no longer supported. Please, upgrade your browser.
ANGO AngioDynamics, Inc. daily Stock Chart
ANGO [NASD]
AngioDynamics, Inc.
Index- P/E67.78 EPS (ttm)0.32 Insider Own0.90% Shs Outstand37.12M Perf Week3.98%
Market Cap795.15M Forward P/E22.96 EPS next Y0.93 Insider Trans0.00% Shs Float36.45M Perf Month-4.59%
Income11.80M PEG3.23 EPS next Q0.18 Inst Own- Short Float5.31% Perf Quarter7.26%
Sales344.30M P/S2.31 EPS this Y111.20% Inst Trans0.16% Short Ratio7.71 Perf Half Y27.73%
Book/sh14.50 P/B1.48 EPS next Y9.38% ROA-1.40% Target Price18.00 Perf Year36.00%
Cash/sh1.44 P/C14.83 EPS next 5Y21.00% ROE-1.90% 52W Range15.16 - 23.95 Perf YTD28.80%
Dividend- P/FCF17.99 EPS past 5Y21.60% ROI1.30% 52W High-10.57% Beta0.99
Dividend %- Quick Ratio1.80 Sales past 5Y9.50% Gross Margin51.40% 52W Low41.29% ATR0.74
Employees1250 Current Ratio2.90 Sales Q/Q-2.00% Oper. Margin-1.40% RSI (14)49.50 Volatility2.31% 3.26%
OptionableYes Debt/Eq0.17 EPS Q/Q226.90% Profit Margin-2.80% Rel Volume1.27 Prev Close21.55
ShortableYes LT Debt/Eq0.16 EarningsJul 11 BMO Payout- Avg Volume251.28K Price21.42
Recom2.80 SMA20-2.51% SMA500.70% SMA20016.90% Volume318,587 Change-0.60%
Apr-03-18Upgrade Raymond James Mkt Perform → Outperform
Jan-05-18Downgrade Craig Hallum Buy → Hold
Apr-07-17Reiterated Cantor Fitzgerald Overweight $20 → $21
Mar-30-17Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Feb-08-17Initiated Barclays Equal Weight $17
Nov-04-16Initiated Cantor Fitzgerald Buy
Apr-08-16Resumed Piper Jaffray Neutral
Jan-08-16Reiterated Canaccord Genuity Buy $17.50 → $14.50
Nov-10-15Downgrade Raymond James Outperform → Mkt Perform
Jul-24-15Initiated KeyBanc Capital Mkts Overweight
Jun-19-14Upgrade Canaccord Genuity Hold → Buy $16.25 → $20
Oct-09-12Reiterated Canaccord Genuity Hold $14 → $13.50
Jun-25-12Downgrade Canaccord Genuity Buy → Hold $16.50 → $14.50
Jul-15-11Upgrade Stifel Nicolaus Hold → Buy $16.50
Jul-15-11Upgrade Canaccord Genuity Hold → Buy $15 → $16.50
Jun-14-11Downgrade Wedbush Neutral → Underperform $14 → $12
Sep-08-10Reiterated Wedbush Neutral $17.50 → $14
Mar-04-10Initiated Wedbush Morgan Neutral $17.50
Sep-04-09Reiterated Caris & Company Above Average $13 → $15
Jul-17-09Reiterated Caris & Company Above Average $15 → $13
Jul-19-18 10:37AM  Medical device company settles US case over false claims Associated Press
10:36AM  Medical device company settles US case over false claims Associated Press
Jul-18-18 05:26PM  AngioDynamics to pay $12.5 mln over false claims allegations -U.S. Justice Dept Reuters
07:00AM  Free Post Earnings Research Report: AngioDynamics' Revenues Improved 1.6%; Adjusted EPS Advanced 5.3% ACCESSWIRE
Jul-17-18 08:13AM  AngioDynamics (ANGO) Q4 Performance Dull, Competition Rife Zacks
Jul-12-18 08:46AM  AngioDynamics (ANGO) Misses Q4 Earnings & Revenue Estimates Zacks +8.18%
02:52AM  Edited Transcript of ANGO earnings conference call or presentation 11-Jul-18 12:00pm GMT Thomson Reuters StreetEvents
Jul-11-18 08:37AM  AngioDynamics (ANGO) Misses Q4 Earnings and Revenue Estimates Zacks -16.08%
07:12AM  AngioDynamics: Fiscal 4Q Earnings Snapshot Associated Press
07:00AM  AngioDynamics Reports Fiscal 2018 Fourth Quarter and Full-Year Financial Results Business Wire
06:00AM  AngioDynamics, Inc. to Host Earnings Call ACCESSWIRE
Jul-10-18 02:33PM  Earnings Preview For AngioDynamics Benzinga
Jul-02-18 08:03AM  What's in Store for AngioDynamics (ANGO) in Q4 Earnings? Zacks
Jun-24-18 09:23AM  Estimating The Intrinsic Value Of AngioDynamics Inc (NASDAQ:ANGO) Simply Wall St.
Jun-21-18 04:01PM  AngioDynamics to Report Fiscal 2018 Fourth Quarter and Full-Year Financial Results on July 11, 2018 Business Wire
May-29-18 08:15AM  Research Report Identifies AngioDynamics, Kaiser Aluminum, Mammoth Energy Services, Meridian Bioscience, Merrimack Pharmaceuticals, and Energizer with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Apr-30-18 01:45AM  Why Is AngioDynamics (ANGO) Up 13.9% Since Its Last Earnings Report? Zacks
Apr-10-18 04:01PM  AngioDynamics to Present at Two Investor Conferences in May Business Wire
Apr-05-18 07:20AM  Blog Exposure - Waters Corp. to Significantly Expand its Precision Chemistry Facility in Massachusetts ACCESSWIRE
Apr-04-18 08:20AM  Recent Analysis Shows Multi-Color, Madrigal Pharmaceuticals, SPX, AngioDynamics, Atara Biotherapeutics, and Quanex Building Products Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Apr-03-18 10:25AM  AngioDynamics (ANGO) Product Line Strong, Debt Level High Zacks +5.57%
Apr-02-18 10:15AM  AngioDynamics (ANGO) Beats on Q3 Earnings, Reiterates View Zacks
Apr-01-18 10:10AM  AngioDynamics (ANGO) Q3 2018 Earnings Conference Call Transcript Motley Fool
Mar-29-18 07:25PM  Edited Transcript of ANGO earnings conference call or presentation 29-Mar-18 12:00pm GMT Thomson Reuters StreetEvents
07:59AM  Where AngioDynamics Inc (NASDAQ:ANGO) Stands In Earnings Growth Against Its Industry Simply Wall St.
07:12AM  AngioDynamics misses 3Q revenue forecasts Associated Press
07:00AM  AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results Business Wire
06:00AM  AngioDynamics, Inc. to Host Earnings Call ACCESSWIRE
Mar-15-18 04:01PM  AngioDynamics to Present at the Needham 17th Annual Healthcare Conference Business Wire
Feb-27-18 04:01PM  AngioDynamics to Report Fiscal 2018 Third Quarter Financial Results on March 29, 2018 Business Wire
Feb-15-18 08:00AM  AngioDynamics to Present at the Barclays Global Healthcare Conference Business Wire
Feb-06-18 08:00AM  Investor Expectations to Drive Momentum within Regal Beloit, Kaiser Aluminum, AngioDynamics, Mulesoft, Assembly Biosciences, and Woodward Discovering Underlying Factors of Influence GlobeNewswire
Jan-26-18 10:56AM  AngioDynamics Receives FDA Nod, to Treat Pancreatic Cancer Zacks
Jan-25-18 07:30AM  Free Post Earnings Research Report: Waters Sales Jumped 9%; Adjusted EPS Surged 14% ACCESSWIRE
Jan-24-18 04:01PM  AngioDynamics Receives FDA Expedited Access Pathway Designation for the NanoKnife® System for the Treatment of Stage III Pancreatic Cancer Business Wire
07:59AM  AngioDynamics (ANGO) Banks on Buyouts, Debt Level High Zacks
Jan-19-18 10:55AM  AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q2, 2018 By the Numbers : January 19, 2018 Capital Cube
Jan-10-18 09:05AM  Zacks.com featured highlights include: AngioDynamics, Zumiez, GP Strategies, AngloGold and Raymond James Zacks
Jan-09-18 07:42AM  Bet on These 5 PEG-Ratio Based GARP Picks Zacks
Jan-05-18 03:30PM  AngioDynamics (ANGO) Misses on Earnings, Revenues in Q2 Zacks
Jan-04-18 08:45PM  Edited Transcript of ANGO earnings conference call or presentation 4-Jan-18 1:00pm GMT Thomson Reuters StreetEvents
07:11AM  AngioDynamics misses Street 2Q forecasts Associated Press
07:00AM  AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results Business Wire
Jan-03-18 01:37PM  Can AngioDynamics (ANGO) Pull a Surprise in Q2 Earnings? Zacks
Dec-28-17 11:48AM  ETFs with exposure to AngioDynamics, Inc. : December 28, 2017 Capital Cube
Dec-19-17 04:01PM  AngioDynamics to Present at the J.P. Morgan Healthcare Conference Business Wire
Dec-15-17 08:00AM  AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : December 15, 2017 Capital Cube
Dec-11-17 04:01PM  AngioDynamics to Report Fiscal 2018 Second Quarter Financial Results on January 4, 2018 Business Wire
Dec-05-17 07:47AM  AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : December 5, 2017 Capital Cube
Nov-24-17 11:12AM  AngioDynamics, Inc. Value Analysis (NASDAQ:ANGO) : November 24, 2017 Capital Cube
Nov-22-17 07:30AM  AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : November 22, 2017 Capital Cube
Oct-30-17 04:11AM  Why Is AngioDynamics (ANGO) Up 5.3% Since the Last Earnings Report? Zacks
Oct-27-17 10:43AM  ETFs with exposure to AngioDynamics, Inc. : October 27, 2017 Capital Cube
Oct-17-17 08:05AM  AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : October 17, 2017 Capital Cube
Oct-11-17 07:40AM  Earnings Review and Free Research Report: AngioDynamics Reported Lower than Expected Quarterly Results ACCESSWIRE
Oct-04-17 10:31AM  ETFs with exposure to AngioDynamics, Inc. : October 4, 2017 Capital Cube
08:51AM  AngioDynamicis' (ANGO) Solero MTA System to Drive Growth Zacks
07:00AM  Earnings Review and Free Research Report: Lakelands Revenue Jumped 7.4%; EPS Surged 25% ACCESSWIRE
Oct-03-17 09:43AM  AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q1, 2018 By the Numbers : October 3, 2017 Capital Cube
07:00AM  Corporate News Blog - Skyline Medical Provides Update on Pending CytoBioscience Merger ACCESSWIRE
Oct-02-17 11:14AM  AngioDynamics, Inc. Value Analysis (NASDAQ:ANGO) : October 2, 2017 Capital Cube
10:08AM  AngioDynamics (ANGO) Misses on Earnings & Revenues in Q1 Zacks
Sep-29-17 08:15AM  AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : September 29, 2017 Capital Cube
Sep-28-17 09:41PM  AngioDynamics misses Street 1Q forecasts Associated Press -13.17%
06:00AM  AngioDynamics Reports Fiscal 2018 First Quarter Results GlobeNewswire
Sep-26-17 07:09AM  Can AngioDynamics (ANGO) Spring a Surprise in Q1 Earnings? Zacks
Sep-18-17 08:06AM  AngioDynamics' BioFlo Platform Strong, Debt Levels High Zacks
Sep-14-17 07:00AM  Outcomes in a Nurse-Led Peripherally Inserted Central Catheter Program: A Retrospective Cohort Study Published in CMAJ Open GlobeNewswire
06:00AM  AngioDynamics to Report Fiscal 2018 First Quarter Financial Results GlobeNewswire
Sep-13-17 06:00AM  AngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Aug-29-17 06:00AM  AngioDynamics to Present at the 2017 Morgan Stanley Global Healthcare Conference GlobeNewswire
Aug-18-17 04:20PM  ETFs with exposure to AngioDynamics, Inc. : August 18, 2017 Capital Cube
03:41AM  AngioDynamics (ANGO) Up 10.8% Since Earnings Report: Can It Continue? Zacks
Aug-12-17 11:40PM  Edited Transcript of ANGO earnings conference call or presentation 18-Jul-17 12:00pm GMT Thomson Reuters StreetEvents
Aug-08-17 09:52AM  AngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q4, 2017 By the Numbers : August 8, 2017 Capital Cube
Aug-07-17 07:49AM  AngioDynamics to Present at the 2017 Canaccord Genuity Growth Conference GlobeNewswire
Jul-27-17 04:25PM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of AngioDynamics, Inc. Business Wire
Jul-26-17 09:19AM  INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of AngioDynamics, Inc. - ANGO PR Newswire
Jul-24-17 06:56PM  INVESTOR ALERT: Goldberg Law PC Announces an Investigation of AngioDynamics, Inc. Business Wire +7.35%
01:21PM  Lifshitz & Miller LLP Announces Investigation of Acacia Communications, Inc., AngioDynamics, Inc., ClubCorp Holdings, Inc., HD Supply Holdings, Inc., Ocular Therapeutix, Inc., Repros Therapeutics Inc. and Tahoe Resources Inc. PR Newswire
Jul-21-17 05:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AngioDynamics, Inc. - ANGO Accesswire
Jul-19-17 09:08AM  AngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : July 19, 2017 Capital Cube
09:08AM  AngioDynamics (ANGO) Shares Down Despite Q4 Earnings Beat Zacks
Jul-18-17 06:23PM  IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of AngioDynamics, Inc. and Encourages Investors with Losses to Contact the Firm Business Wire -6.78%
06:21PM  ANGIODYNAMICS (ANGO) INVESTOR ALERT: Legal Investigation for Potential Securities Law Violations Business Wire
05:43PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of AngioDynamics, Inc. Business Wire
04:49PM  AngioDynamics reports 4Q loss Associated Press
03:28PM  IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of AngioDynamics, Inc. Business Wire
02:32PM  ANGIODYNAMICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In AngioDynamics, Inc. To Contact The Firm PR Newswire
02:11PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AngioDynamics, Inc. (ANGO) PR Newswire
01:05PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of AngioDynamics, Inc. Business Wire
12:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AngioDynamics, Inc. - ANGO PR Newswire
06:00AM  AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results GlobeNewswire
Jul-07-17 06:00AM  AngioDynamics to Report Fiscal 2017 Fourth Quarter and Full-Year Financial Results GlobeNewswire
Jun-15-17 04:06PM  AngioDynamics, Inc. Value Analysis (NASDAQ:ANGO) : June 15, 2017 Capital Cube
01:03PM  ETFs with exposure to AngioDynamics, Inc. : June 15, 2017 Capital Cube
Jun-14-17 08:20AM  AngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : June 14, 2017 Capital Cube
Jun-09-17 08:15AM  Featured Company News - Medical Devices Company AngioDynamics Receives FDA Clearance for Solero MTA System Accesswire
Jun-07-17 06:00AM  AngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation System GlobeNewswire
May-31-17 03:48PM  Albany public company files lawsuit alleging competitor violated antitrust laws American City Business Journals
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings in the United States and internationally. The company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; Asclera drug for treating uncomplicated spider and reticular veins of the lower extremities; and Sotradecol drugs for treating small uncomplicated varicose veins of the lower extremities. It also offers AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. In addition, the company provides thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage products, which drain abscesses and other fluid pockets; and micro access sets. Further, it offers peripherally inserted central catheters; ports that are implantable devices for the central venous administration; and dialysis products. Additionally, the company provides microwave ablation products; radiofrequency ablation products for ablating solid cancerous or benign tumors; and NanoKnife ablation systems for the surgical ablation of soft tissues. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, and interventional and surgical oncologists directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GOLD JEFFREYDirectorJul 06Option Exercise13.537,00094,71070,906Jul 10 06:44 PM
JOHNSON WESLEYDirectorJun 22Option Exercise13.5314,000189,42060,974Jun 25 04:20 PM
Meteny Dennis SDirectorJun 21Option Exercise13.5314,000189,42083,127Jun 25 04:30 PM
DONNELLY HOWARD WDirectorJun 21Option Exercise10.686,65071,02265,353Jun 25 04:26 PM
GOLD JEFFREYDirectorJun 21Option Exercise13.537,00094,71068,134Jun 25 04:23 PM
DONNELLY HOWARD WDirectorNov 21Option Exercise13.5314,000189,42069,576Nov 22 01:48 PM
Richard StarkSVP, GM - OncologyNov 15Option Exercise11.4527,409313,81548,163Nov 17 04:08 PM
Richard StarkSVP, GM - OncologyNov 15Sale16.2927,409446,49320,754Nov 17 04:08 PM
Gould Kevin JDirectorSep 12Option Exercise14.0339,000547,17065,064Sep 14 03:24 PM
JOHNSON WESLEYDirectorJul 25Option Exercise15.7514,000220,50060,974Aug 08 05:48 PM
Meteny Dennis SDirectorJul 25Option Exercise15.7514,000220,50083,127Aug 08 05:44 PM
GOLD JEFFREYDirectorJul 25Option Exercise15.7514,000220,50066,037Jul 28 03:47 PM
REED JAN STERNDirectorJul 24Buy16.003165,056316Jul 25 02:33 PM